NTRK3 and metastatic melanoma: The overexpression of TrkC has been documented in several cancers, such as BC (Mortensen et al. 2021), hepatocellular carcinoma (Wang et al. 2023), and metastatic melanoma (Lezcano et al. 2018, Forschner et al. 2020).